BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 31043166)

  • 21. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
    He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
    Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
    Li Z; Xu J; Cui H; Song J; Chen J; Wei J
    Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioinformatics analysis of gene expression profiles in hepatocellular carcinoma.
    Shangguan H; Tan SY; Zhang JR
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2054-61. PubMed ID: 26125269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
    Sun Q; Liu P; Long B; Zhu Y; Liu T
    Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma.
    Jiang CH; Yuan X; Li JF; Xie YF; Zhang AZ; Wang XL; Yang L; Liu CX; Liang WH; Pang LJ; Zou H; Cui XB; Shen XH; Qi Y; Jiang JF; Gu WY; Li F; Hu JM
    J Transl Med; 2020 Jan; 18(1):40. PubMed ID: 32000807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics analysis of different candidate genes involved in hepatocellular carcinoma induced by HepG2 cells or tumor cells of patients.
    Zhang X; Yin S; Ma K
    J Int Med Res; 2020 Jun; 48(6):300060520932112. PubMed ID: 32567431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma.
    Zhen L; Ning G; Wu L; Zheng Y; Yang F; Chen T; Xu W; Liu Y; Xie C; Peng L
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32955083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
    Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
    Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Molecular Nanoprobes in the Analysis of Differentially Expressed Genes and Prognostic Models of Primary Hepatocellular Carcinoma.
    Luo S; Gan L; Luo Y; Zhang Z; Li L; Wang H; Li T; Chen Q; Huang Y; He J; Zhong L; Liu X; Wu P; Wang Y; Zhao Y; Zhang Z
    J Biomed Nanotechnol; 2021 Jun; 17(6):1020-1033. PubMed ID: 34167617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.
    Chen Z; Chen J; Huang X; Wu Y; Huang K; Xu W; Xie L; Zhang X; Liu H
    J Comput Biol; 2019 May; 26(5):485-494. PubMed ID: 30864827
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of Key Biological Processes, Pathways, Networks, and Genes with Potential Prognostic Values in Hepatocellular Carcinoma Using a Bioinformatics Approach.
    Lu H; Zhu Q
    Cancer Biother Radiopharm; 2021 Dec; 36(10):837-849. PubMed ID: 32598174
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma.
    Jiang X; Zhang W; Li L; Xie S
    Pathol Oncol Res; 2021; 27():1609985. PubMed ID: 34737677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular Carcinoma.
    Chen D; Feng Z; Zhou M; Ren Z; Zhang F; Li Y
    Biomed Res Int; 2021; 2021():4092635. PubMed ID: 34746301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.
    Wu Y; Yao N; Feng Y; Tian Z; Yang Y; Zhao Y
    Oncol Rep; 2019 Sep; 42(3):937-952. PubMed ID: 31322260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.